HYCOR hires Sean-Xavier Neath as CMO
This article was originally published in Scrip
HYCOR Biomedical, a manufacturer and marketer of in vitro diagnostic products, has appointed Dr Sean-Xavier Neath chief medical officer. Dr Neath has served in medical affairs positions for a number of companies including Brahms USA, where he led new product development strategies, and Biosite.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.